The U.S. Federal Reserve is in no rush to cut its short-term interest rate again given an economy that is "strong overall," ...
Goldman Sachs will drop a demand that corporate boards of directors include women and members of minority groups as financial ...
UBS analysts increased the price target on Axsome Therapeutics (NASDAQ:AXSM) shares to $133.00, up from the previous $105.00, while maintaining a Buy rating on the stock. The company, currently valued ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results